The global radiosurgery systems market revenue was around US$ 2.24 billion in 2022 and is estimated to reach US$ 4.01 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period from 2023 to 2031.
The radiology systems are used in the field of neurology to treat various neurological diseases using radiosurgery procedures. Radiosurgery is a non-invasive surgical procedure that utilizes highly concentrated radiation beams to target and treat distinct areas of the nervous system or brain.
Market Driving Factors
Increasing demand for non-invasive treatments is estimated to drive the market growth. This is due to the radiosurgery systems provide non-invasive treatment choices for several neurological conditions, including arteriovenous malformations (AVMs), brain tumors, essential tremors, and trigeminal neuralgia. In addition, the demand for radiosurgery systems has grown as patients seek options for conventional surgery,
Surging awareness and education is expected to boost the market growth. This is primarily due to the both patients and healthcare providers are becoming more knowledgeable about the advantages of radiosurgery systems because of advances in medical education and awareness campaigns. As a result, this surge in awareness has contributed to the increasing adoption of radiosurgery systems.
Technological advancements to cure disease in a better way provide opportunities in the market. Technological advancements have significantly enhanced the accuracy, precision, and safety of radiosurgery systems. Additionally, the development of real-time imaging, image-guided systems, and robotic-assisted platforms has made radiosurgery more effective and minimally invasive, leading to raised adoption of radiosurgery systems.
Most underdeveloped nations are unable to grow economically because the sophisticated technology of radiation therapy is too costly. Thus, this element impedes market expansion.
Regional Analysis
North America dominated the market in terms of revenue and is estimated to maintain its dominance. This is mainly attributed to the surge in the number of research activities, technological advances in the healthcare sector, the rise in the prevalence of chronic conditions, and the existence of key players who manufacture radiosurgery systems in the region.
Asia-Pacific dominates the market in terms of the largest shares. This is due to the increase in expenditure by government organizations to create the healthcare sector, the surge in the prevalence of chronic disorders, and the increase in the geriatric population.
Segmentation Insights
Type Insight
The gamma knife system segment dominated the market in terms of growth rate and is estimated to continue its dominance. This can be attributed to neurological disorders and brain tumors and, the immediate adoption of gamma knife radiosurgery as an effective treatment option.
The proton beam therapy segment is expected to dominate the market. This is due to the surge in the usage of proton beam therapy in the treatment of tumors and cancer, minor side effects, and high effectiveness associated with proton beam therapy compared to other radiosurgery systems.
Condition Insight
The brain tumor segment dominates the market in terms of revenue. This is owing to the surge in the prevalence of brain tumors and brain cancer, technological advances in the healthcare sector, and the rise in awareness among individuals regarding health importance.
The spine segment is estimated to dominate the market in terms of growth rate. This is mainly owing to the increase in the prevalence of spinal cord cancer, the rise in awareness about spinal cord tumors, and the surge in the number of experts who conduct surgeries for spine tumor treatment.
End User Insight
The academic & research institutes segment is predicted to dominate the market in terms of the largest shares. This is primarily owing to the surge in the number of research and development activities and the rise in the number of experts who conduct research activities.
Prominent Companies
Segmentation Outline
The global radiosurgery systems market segmentation focuses on the Type, Condition, End User, and Region.
By Type
By Condition
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL RADIOSURGERY SYSTEMS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: RADIOSURGERY SYSTEMS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL RADIOSURGERY SYSTEMS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL RADIOSURGERY SYSTEMS MARKET, BY TYPE
5.1 OVERVIEW
5.2 LINEAR ACCELERATOR SYSTEMS
5.3 PROTON BEAM THERAPY
5.4 GAMMA KNIFE SYSTEM
6 GLOBAL RADIOSURGERY SYSTEMS MARKET, BY CONDITION
6.1 OVERVIEW
6.2 BRAIN TUMORS
6.2.1 MALIGNANT
6.2.2 NON MALIGNANT
6.3 SPINE TUMORS
7 GLOBAL RADIOSURGERY SYSTEMS MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 ACADEMIC AND RESEARCH INSTITUTE
8 GLOBAL RADIOSURGERY SYSTEMS MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL RADIOSURGERY SYSTEMS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 ZAP SURGICAL SYSTEM INC.
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 ATRIUM HEALTH
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 AVOCURE
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 BRAINLAB
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 ELEKTA AB
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 VIEWRAY
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 SIEMENS (VARIAN MEDICAL SYSTEMS)
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 MEVION MEDICAL SYSTEMS INC
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 XCISION MEDICAL SYSTEMS
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 SUMMIT CANCER CENTERS
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 VISION RT LTD
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 INTEGRA LIFESCIENCES HOLDING CORP
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 MEDTRONIC
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 NORDION INC.
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.15 ACCURAY INCORPORATED
10.15.1 OVERVIEW
10.15.2 FINANCIAL PERFORMANCE
10.15.3 PRODUCT OUTLOOK
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.16 ION BEAM APPLICATIONS SA
10.16.1 OVERVIEW
10.16.2 FINANCIAL PERFORMANCE
10.16.3 PRODUCT OUTLOOK
10.16.4 KEY DEVELOPMENTS
10.16.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.17 REFLEXION MEDICAL
10.17.1 OVERVIEW
10.17.2 FINANCIAL PERFORMANCE
10.17.3 PRODUCT OUTLOOK
10.17.4 KEY DEVELOPMENTS
10.17.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved